The Food and Drug Administration (FDA) has granted accelerated approval to Avmapki ™ (avutometinib) plus Fakzynja ™ (defactinib) for the treatment of adult patients with KRAS -mutated recurrent ...

Topline data were announced from two phase 3 studies evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

Introduction of pregnancy checkbox associated with increase in reported maternal mortality of 6.78 deaths per 100,000 livebirths.

HealthDay News — A quality improvement program can improve recommended antibiotic duration in children for both acute otitis media (AOM) and community-acquired pneumonia (CAP) across multiple care ...

The US Food and Drug Administration has chosen Dr Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

In the past, longer trips were seen as a way to group several inspections into one trip, saving money and reducing the strain of traveling.

The approach could mean no COVID boosters will be approved in time for next winter’s respiratory disease season, Makary has warned in earlier interviews.

All the people were infected with the same strain of salmonella, which has been linked to poultry hatcheries in the past.

In termination letters to researchers, the NIH said their LGTBQ work "no longer effectuates agency priorities." ...

Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2.

HealthDay News — Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online April 29 in Menopause.